View Clinical Trial (Medical Research Study)


A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer. - NCT00700102-68114(Clinical Trial 691187)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup

City:  Omaha
State:  
NE
Zip Code: 68114
Conditions: Colorectal Cancer
Purpose: This study will evaluate the efficacy and safety of adding Avastin to crossover fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer who have experienced disease progression under first line treatment with standard chemotherapy plus Avastin. Patients will be randomized to one of 2 chemotherapy strata. Those in stratum 1 will receive chemotherapy (AIO-IRI, FOLFIRI, CAPIRI or XELIRI) alone, or in combination with Avastin (5mg/kg iv on days 1 and 14 of each 4 week cycle or 7.5mg/kg on days 1 and 22 of each 6 week cycle) and those in stratum 2 will receive chemotherapy (FUFOX, FOLFOX, CAPOX or XELOX) alone, or in combination with Avastin (5mg/kg on days 1 and 14 of each 4 week cycle or 7.5mg/kg on days 1 and 22 of each 6 week cycle). The anticipated time on study treatment is until disease progression, and the target sample size is 500+ individuals.
Study summary:
Criteria: Inclusion Criteria: - adult patients, >=18 years of age; - metastatic colorectal cancer and disease progression, previously treated with first-line chemotherapy plus Avastin; - ECOG <=2. Exclusion Criteria: - first line patients with progression-free survival in first line of <4 months; - other malignancies, except for curatively treated basal and squamous cell cancer of the skin or in situ cancer of the cervix; - clinically significant cardiovascular disease within 1 year of randomization; - CNS metastases.
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: October 7, 2010
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.